What Pharmacy Does MEDVi Use? The 3 Partners MEDVi Names

By WPG Research Team · Last verified November 7, 2026 · Last updated November 7, 2026

MEDVi names three partner pharmacies: Triad Rx in Daphne, Alabama; Red Rock Pharmacy in St. George, Utah; and Beaker Pharmacy & Compounding in McKinney, Texas. MEDVi is not a pharmacy and doesn't make the drugs. None of the three is an FDA-registered 503B facility. Your label shows which one filled your order.

That last part matters more than the list. MEDVi doesn't say which pharmacy fills which product. So below, we lay out each pharmacy's public record, what it means in plain English, and how to check the one on your label in about five minutes.

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers.

Bottom line: MEDVi is open about who its pharmacies are, which many telehealth brands aren't. The record is mixed. Triad Rx had a 2019 FDA warning letter that FDA closed in 2023. Red Rock's company got a 10-item FDA inspection report (Form 483) in July 2026 at its Springville, Utah site. Beaker had no FDA compounding action we could find.

Best for: Cash-pay adults who are fine with compounded medicine, want to know who makes it, and will check their label.

Not best for: Anyone who wants only FDA-approved, brand-name medicine from a manufacturer's supply chain. Ro sells only FDA-approved GLP-1s.

What matters most: Compounded drugs are not FDA-approved, whichever pharmacy makes them. The pharmacy name on your label is the one to check.

What pharmacy does MEDVi use? The partners at a glance

This is the table we wished existed when we started. It puts MEDVi's own list next to the federal records we pulled on November 7, 2026.

Sources: MEDVi's site footer, FDA's compounding inspections page (content current October 22, 2026), FDA's 503B list, and the federal NPI registry. Links are in Sources at the bottom.

A quick translation of the jargon:

• Compounded means a pharmacy mixes the drug itself instead of buying the maker's finished product. FDA does not review compounded drugs for safety, effectiveness or quality before they reach you.
• 503A pharmacy means a state-licensed pharmacy that compounds for one named patient at a time, with a prescription. Your state board of pharmacy is its main watchdog.
• 503B outsourcing facility means a larger compounder that registers with FDA and must follow factory-style quality rules. None of MEDVi's three named partners is on FDA's 503B list.
• Form 483 is the list an FDA inspector hands over at the end of a visit. It records what the inspector saw. It is not a final FDA ruling.

Does MEDVi have its own pharmacy?

No. MEDVi is a telehealth brand, not a pharmacy. Its own fine print says "MEDVi is not acting as a pharmacy" and "MEDVi does not produce compounded medications." Licensed clinicians from OpenLoop Health decide whether to prescribe, and a partner pharmacy fills and ships the order.

Think of MEDVi as the front desk. The clinician writes the order. The pharmacy makes and mails the medicine. Three different companies touch your prescription.

MEDVi also warns that "individuals may receive medication that looks different than what is portrayed on the website." That's normal for compounded drugs. It's also why the label, not the website photo, is your proof of who made it.

The right GLP-1 path isn't the same for everyone. It depends on your state, your insurance, your budget, and whether you want FDA-approved or compounded medicine, shot or pill. If you're still deciding whether a compounded program is even right for you, our free tool sorts that out first.

What we actually verified (November 7, 2026)

• MEDVi's partner list: read on home.medvi.org and glp1.medvi.org. Both name Triad Rx, Red Rock Pharmacy and Beaker Pharmacy & Compounding, with addresses.
• FDA's compounding actions page: lists Triad Rx (Daphne, AL) and CD Pharmacy LLC, doing business as Red Rock Pharmacy (Springville, UT), as 503A facilities. No entry for Beaker.
• FDA's 503B outsourcing facility list: none of the three appears.
• Red Rock's Form 483: we read the PDF itself, dated July 31, 2026.
• Triad's letters: we read the 2019 warning letter and the 2023 close-out on fda.gov.
• Federal NPI registry: confirmed the legal names and that MEDVi's St. George address belongs to the same company (CD Pharmacy LLC) that runs the Springville site.
• What we could not confirm: which MEDVi product each pharmacy fills, which pharmacy fills MEDVi's brand-name Wegovy or Zepbound orders, and each pharmacy's license in your state.

Triad Rx (Daphne, Alabama)

Triad Rx is a compounding pharmacy in Daphne, Alabama. FDA sent it a warning letter in 2019 and closed that letter in 2023. The current federal NPI record for the Daphne address lists the owner as Triad Rx Buyer LLC, a different legal name than the one on FDA's letters (Triad Rx, Inc.).

What FDA found in 2017, as described in its February 5, 2019 warning letter:

• The pharmacy compounded drugs from ingredients (GHRP-2, GHRP-6 and chromium picolinate) that don't qualify under the 503A rules.
• The inspector saw "serious deficiencies" in how it made sterile drugs, such as staff movements blocking clean airflow over open vials.

FDA inspected again in December 2022 and issued a Form 483. In May 2023, FDA wrote that Triad had "adequately addressed the violations" and closed the warning letter. That close-out letter also says, "We acknowledge that your firm no longer produces sterile drug products."

Why that line matters to you: injectable GLP-1s are sterile products. As of FDA's 2023 letter, Triad wasn't making sterile drugs. That may have changed since. MEDVi doesn't say what Triad fills for it. If your injection vial says Triad Rx, it's a fair question to ask MEDVi.

Red Rock Pharmacy (St. George, Utah)

Red Rock Pharmacy is the trade name of CD Pharmacy LLC, a Utah company with more than one location. FDA inspected its Springville, Utah site in July 2026 and issued a Form 483 with 10 observations. MEDVi lists the company's St. George address. The federal NPI registry shows both addresses belong to CD Pharmacy LLC.

The inspection ran July 21 to 31, 2026. In plain English, the inspector wrote that:

• A worker spotted a suspected glass particle in one vial from a liraglutide injection lot. The pharmacy refilled the solution as a new lot with a later use-by date and shipped units from it, without confirming what the particle was.
• The pharmacy's sterility tests ("media fills" and "smoke studies") didn't match real working conditions. The inspector watched technicians fill semaglutide and tirzepatide-with-B12 vials at the same time in the same clean hood.

Two fair points on the other side. A Form 483 is a list of observations, not a final FDA ruling, and the form says so. And the 483 went to Springville, not to the St. George address MEDVi lists. FDA's page showed no warning letter for Red Rock as of its October 22, 2026 update.

Two more things we noticed. Red Rock also fills prescriptions for other brands: Hims & Hers names "CD Pharmacy LLC ... d/b/a Red Rock Pharmacy" in its own terms. And MEDVi's homepage lists two different phone numbers for Red Rock, (435) 703-2900 and (801) 433-9500. Use the number on your label or the pharmacy's own site.

Beaker Pharmacy & Compounding (McKinney, Texas)

Beaker is a retail and compounding pharmacy in McKinney, Texas. We found no FDA warning letter, Form 483 or compounding action for it. Its NPI record lists the legal name Apteek Rx, doing business as Beaker Pharmacy, with a compounding pharmacy classification.

Beaker's homepage talks about compounding hormones, skin creams, children's medicines and more. It doesn't list GLP-1s there. That doesn't mean it can't fill them for MEDVi. It means you can't confirm it from the homepage alone.

A clean federal record is good news, not a guarantee. For a 503A pharmacy, the Texas State Board of Pharmacy is the main regulator, and FDA inspects mostly when there's a reason to.

Is MEDVi's pharmacy setup a red flag?

Naming your pharmacies is a good sign. The records behind two of the names are a reason to check your label, not a reason to panic. Many telehealth brands name no pharmacy at all. MEDVi names three, with addresses.

Here's how we'd weigh it:

MEDVi's own site says its compounded drugs "are produced in FDA-regulated facilities." That's true in a narrow sense: FDA can inspect any pharmacy. But a 503A pharmacy is mainly overseen by its state board, and the finished compounded drug is still not FDA-approved.

The FDA warning letter to MEDVi

On February 20, 2026, FDA sent MEDVi, LLC a warning letter about its website claims for compounded semaglutide and tirzepatide. FDA said product photos with "MEDVi" on the label suggested MEDVi made the drugs "when in fact it is not" the compounder. FDA also objected to claims that the drugs had the same active ingredient as brand-name medicines.

That letter is about marketing, not about a pharmacy failing a test. But it ties right into this page. The whole point is that MEDVi doesn't make the medicine. A partner pharmacy does. Read the FDA warning letter to MEDVi. For more on drug status, see is MEDVi GLP-1 FDA approved.

Safety note for any GLP-1: do not use one if you or a family member has had medullary thyroid cancer (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). That rule comes from the FDA labels for brand-name GLP-1s. A licensed clinician decides if any GLP-1 fits you.

Still want MEDVi? Do these 3 checks first

If you're comfortable with compounded medicine after reading the record, MEDVi is a reasonable cash-pay option to look at. It names its pharmacies, says medicine is included in its compounded program price, and accepts HSA and FSA cards. Brand-name Wegovy and Zepbound paths are listed at "$99 Membership + Medication Cost."

Before you pay, three quick yeses:

1. Are you okay with a compounded drug that is not FDA-approved?
2. Will you check the pharmacy name on your first box against your state board's license lookup?
3. Have you read MEDVi's February 2026 FDA warning letter?

Three yeses? Then MEDVi's intake is the next step. For the dollar side, our MEDVi cost breakdown has the plan math.

If you want FDA-approved medicine instead

If the pharmacy questions above bother you, the cleanest fix is a brand-name, FDA-approved GLP-1. Brand-name drugs come from the manufacturer's own approved supply chain, so there's no compounding pharmacy to check.

Ro sells only FDA-approved GLP-1s. On November 7, 2026, Ro listed the Wegovy pill and Foundayo pill at $149 a month to start and the Wegovy pen at $199 a month, cash. Ro's membership is $39 for the first month, refunded if you're not eligible, then $74 to $149 a month depending on the plan. Medicine is billed separately. Ro says its cash prices match LillyDirect, NovoCare and TrumpRx.

Say you're paying cash, you want a pill, and you'd rather never read another Form 483. That's the reader Ro fits.

Switching from MEDVi already? Our switching from MEDVi to Ro guide walks through it.

How to find out which pharmacy filled your MEDVi order

Look at the label on your box or vial. A filled prescription label lists the pharmacy that dispensed it, with its address. That name, not MEDVi's, is the one to check.

1. Find the pharmacy name and address on the label or the paperwork in the box.
2. Match it to MEDVi's list: Triad Rx (Daphne, AL), Red Rock Pharmacy (Utah) or Beaker Pharmacy & Compounding (McKinney, TX).
3. Check its license in its home state and in your state. FDA's BeSafeRx page links every state board's lookup.
4. Search FDA's compounding actions page for the pharmacy's legal name (for Red Rock, that's "CD Pharmacy").
5. If the label names a pharmacy not on MEDVi's list, ask MEDVi before you use it: help@medvi.org or (323) 690-1564.

Our step-by-step guide to verifying a compounding pharmacy license and our list of GLP-1 pharmacy label red flags go deeper.

How MEDVi compares on pharmacy disclosure

For the difference between pharmacy types, see 503A vs 503B compounding pharmacies. Pharmacy verification is one of the six factors we weigh for every provider; see how we rank.

FAQ

What pharmacy does MEDVi use?

MEDVi names three partner pharmacies on its website: Triad Rx in Daphne, Alabama; Red Rock Pharmacy in St. George, Utah; and Beaker Pharmacy & Compounding in McKinney, Texas. MEDVi doesn't say which one fills which product. Your label shows which pharmacy filled your order.

Is MEDVi a pharmacy?

No. MEDVi's own terms say it is "not acting as a pharmacy" and does not produce compounded medications. Clinicians in the OpenLoop Health network prescribe, and a partner pharmacy fills and ships.

Does MEDVi use a 503A or 503B pharmacy?

FDA lists Triad Rx and Red Rock Pharmacy as 503A facilities. Beaker is not on FDA's 503B outsourcing list. None of MEDVi's three named partners was on the 503B list when we checked on November 7, 2026.

Does MEDVi use Belmar Pharma?

Some older reviews online name Belmar. MEDVi's own pharmacy list, checked November 7, 2026, does not include Belmar. It names Triad Rx, Red Rock Pharmacy and Beaker Pharmacy & Compounding.

Has Red Rock Pharmacy had FDA problems?

FDA inspected Red Rock's Springville, Utah site in July 2026 and issued a Form 483 with 10 observations, including sterility-test concerns during semaglutide and tirzepatide filling. A 483 is not a final FDA ruling. FDA's page showed no warning letter for Red Rock as of its October 22, 2026 update.

Are MEDVi's medications FDA-approved?

MEDVi's compounded semaglutide and tirzepatide are not FDA-approved, and MEDVi says so itself. The brand-name Wegovy and Zepbound it also lists are FDA-approved, but those are different products from compounded versions.

Who do I contact about my MEDVi pharmacy?

Start with MEDVi at help@medvi.org or (323) 690-1564. For questions about the medicine itself, call the pharmacy named on your label. Report side effects or quality problems to FDA's MedWatch program.

Claim check summary

Sources

All checked November 7, 2026.

• MEDVi: homepage and partner pharmacy list
• MEDVi: GLP-1 storefront
• FDA: warning letter to MEDVi, LLC (Feb 20, 2026)
• FDA: Compounding inspections, recalls, and other actions
• FDA: Form 483, CD Pharmacy LLC dba Red Rock Pharmacy (July 31, 2026)
• FDA: warning letter to Triad Rx, Inc. (Feb 5, 2019)
• FDA: close-out letter to Triad Rx, Inc. (May 3, 2023)
• FDA: registered 503B outsourcing facilities
• CMS: NPPES NPI Registry
• FDA: concerns with unapproved GLP-1 drugs used for weight loss
• FDA: BeSafeRx, state pharmacy license lookups
• Hims & Hers: terms and conditions (pharmacy list)
• Ro: weight loss pricing
• Wegovy prescribing information

Still not sure which GLP-1 path fits you? Take our free Find My GLP-1 Path quiz — about 2 minutes, no signup.

MEDVi pharmacy partners in the full tirzepatide review

MEDVi's pharmacy setup compared with Ro

MEDVi pharmacy partners compared with Remedy Meds

What pharmacy does Embody use?

What pharmacy does TrimRx use?

Is MEDVi GLP-1 FDA-approved?